This essay presents a pharmacologist's perspective of what would be now called 'preclinical research' and 'uncontrolled clinical trials' surrounding the first public demonstration by William Thomas Green Morton of painless surgery achieved by the inhalation of ether in a patient at the Massachusetts General Hospital on 16 October 1846. Of the many people who made history in those earliest days of surgical anaesthesia in both the United States and Great Britain, John Snow stands out for his personal research that spanned basic science and clinical medicine. Primarily, Snow used the relationship between the vapour pressure of a volatile liquid and temperature to design a vaporiser. This allowed control of the inspired concentration of the volatile liquid epitomised by diethyl ether, and thus the time-course and depth of anaesthesia. In an era when developments in anaesthesia were almost exclusively based on empirical modifications to apparatus and technique, Snow, and to a lesser extent his contemporary Andrew Buchanan, stood out from all others in advancing the quantitative basis of anaesthesia. Both described the physiological basis of control over gas uptake whereby they related that gas moved across concentration gradients in the body: alveolar to arterial to tissue to venous gas tensions, and Snow devised a progressional semi-quantitative scale of five 'stages' of ether anaesthesia. They thereby introduced the elements of what would be referred to 'pharmacokinetics' and 'pharmacodynamics', a century later. This essay attempts to place them and their scientific insights into context with contemporaneous principal personae and knowledge.
Introduction
There are many accounts of the history of anaesthesia and the people who made that history 1, 2 . Among those people, John Snow (1813-1858) stands out for his research that spanned basic science and clinical medicine [3] [4] [5] . This essay presents a pharmacologist's perspective of some aspects of what we would now call 'preclinical research' and 'uncontrolled clinical trials' in the period surrounding the early demonstrations and adoption of ether anaesthesia in 1846-1847. It attempts to place Snow's concepts, of what we would now call 'pharmacokinetics' and 'pharmacodynamics', into the context of 'etherisation' during that period.
Ether: the agent of change
In 1846, ether had already been known chemically for several centuries and was, at that time, recommended by inhalation for asthma, bronchiolitis, and many other diseases, as well as for its exhilarating and intoxicating effects if used for recreational purposes 6, 7 . As a candidate anaesthetic agent, ether was mentioned in a brief anonymous article in 1818 attributed to Michael Faraday, then a student of Humphry Davy at the Royal Institution in London 8 . The article states "When the vapour of ether mixed with common air is inhaled, it produces effects very similar to those occasioned by nitrous oxide." [and] "…It is necessary to use caution in making experiments of this kind. By the imprudent inspiration of ether, a gentleman was thrown into a very lethargic state… [and] …considerable fears were entertained for his life." A serious caution! At that time, ether was formally referred to as 'sulphuric ether', because of its method of synthesis from the dehydration of ethyl alcohol by sulphuric acid, or 'oxide of ethyle'. This method of synthesis normally leaves the ether with residual amounts of sulphurous acid, water and unreacted alcohol, and these can be removed by selective purification. With time, ether became referred to 'anaesthetic ether' by those more at home in the operating theatre, and 'diethyl ether' by those more at home in the laboratory. The latter was an acknowledgement that diethyl ether is but a single example of the chemical class of oxygen bridge characterised organic compounds designated 'ethers'. As a chemical substance, it was, and remains, a commonlyused laboratory organic solvent, that is particularly useful for separating organic from aqueous phases where the organic phase is to be later concentrated by evaporation. For example, ether was used in this way five decades ago, for extracting drugs, such as local anaesthetic agents 9 , from biological matrices in early studies of their pharmacokinetics to better understand their pharmacology.
The ether demonstration
Much is written about William Thomas Green Morton-the Boston dentist and medical student-as the principal person historically associated with the clinical introduction of ether anaesthesia in 1846-and not all accounts concur about his role in that history 10 . In one of these accounts, 'Trials of a Public Benefactor', Nathan P. Rice's 1859 hagiography of Morton 11 , we are told that Morton considered that perhaps …ether, if rubbed or laid upon a mucous membrane, would produce such an amount of local insensibility, what prevented its being used in larger quantities, and upon a more extended surface of membrane, so as to produce a general insensibility? But the important issues that Morton contemplated were, "How is this to be done? Why not…by the same means… [as] nitrous oxide gas…it can be inhaled, and taken into the lungs…" But the question remained in Morton's mind "Is it safe?" "How long could they [the subjects] be asleep and completely recover?" The experience of the ether frolics suggested that people could become 'dead drunk', to sleep, and then completely recover after a short time. Morton thus went ahead-but his preclinical research was brief -and not very enlightening.
During August and September of 1846, Morton performed some rather crude experiments involving the inhalation of ether-on some goldfish, a hen, his pet spaniel, several human volunteer subjects, including himself. Morton observed that the various subjects differed somewhat in their effects but, most importantly, all recovered. With this, Morton's preclinical research was done, and he required a more reliable method for inhaling the vapour. Even so, he was now ready for a clinical trial-to use ether on a cooperative dental patient. After another trial of anaesthetising himself for a period "between seven and eight minutes" on 30 September 1846, that evening Morton performed the painless extraction of an ulcerated tooth of his etherised patient Eben [Ebenezer Hopkins] Frost and, it being dark "Dr Hayden held the lamp" 12 . Perhaps he didn't truly appreciate the flammability of ether! Morton was next invited to appear for a demonstration at the Massachusetts General Hospital at 10am on Friday, 16 October 1846. This demonstration, as is well-known, changed medicine forever 13 .
To conceal the identification of his 'new gas' for the purpose of patenting, Morton called it "Letheon", which was diethyl ether disguised by a fragrance thought to be orange extract 14 . After a second demonstration on the following day, to the surprise of Dr Morton, the ether practice was discontinued because "…the surgeons of the hospital thought it their duty to decline the use of the preparation until informed what it [Morton's substance] was". On 27 October 1846, Charles Thomas Jackson and William TG Morton applied for a patent. On 7 November 1846, Morton "informed them it was sulphuric ether". Senior surgeon Warren then relented his ban on the use of Morton's preparation (ether), and surgery under etherization recommenced 15 . Many other operations were subsequently performed "without the slightest objections on this score". Rice tells us that Dr Morton "continued in charge of the anaesthetical portion of the test experiments". On 12 November, US Patent No 4848 titled Improvement in Surgical Operations to Jackson and Morton was granted. The agent used, sulphuric ether, was not novel-and thus was not patentable. Neither was inhalation of ether-it also was known and used. Nor did the patent suggest that there was anything new about the sulphuric ether used. They were claiming the 'process for the improvement of surgical operations'. However, the matters of the patent, and claims (and counter-claims) for the title of the originator of what would later become known as the 'state of anaesthesia' would lead to a prolonged war of words that would drastically diminish scientific progress on understanding the effects of ether in the United States for a generation 16 . Moreover, even the claiming of a patent by a 'medical man' at that time would, in itself, have been seen as demeaning of the profession 17 -and such claims would have been regarded as no better than those for 'patent medicines' by the 'snakeoil salesmen'.
Nevertheless, progress through the uncontrolled clinical trials of surgical anaesthesia by human experiment thereby began.
The admixture with science
Henry Jacob Bigelow, a junior surgeon and witness to Morton's 16 October demonstration, wrote the first detailed account about it. It was read to medical societies on 3 and 9 November, and a full paper was published in the Boston Medical and Surgical Journal of 18 November, 1846 18 . It was also reprinted largely intact by the Boston Daily Advertiser, and this was sent by his father, Professor Jacob Bigelow, with a letter to his American expatriate friend, Dr Francis Boott, in London.
In London, on 19 December, two days after Boott's receipt of Bigelow's letter, James Robinson, highly respected Surgeon-Dentist to the Metropolitan Free Hospital and friend of Francis Boott, administered ether by an improvised inhaler for the painless extraction of a diseased lower molar tooth 19 . However, its intended repetition in other patients a few days later had only mixed success 20 , a scenario that turned out to be not uncommon-due, in part, to design deficiencies in the administration apparatus. Robinson and Boott soon improved the apparatus, mainly by valves to preclude rebreathing and mouth-piece designs 21 , and performed many demonstrations of the administration of ether for surgery to professional colleagues who emulated what they saw-also with varying extents of success. Robinson wrote of his own experiences, with a collection of reports of the experiences of numerous others during the first few months of 1847, in a book that he dedicated to Boott (Figure 1 ) 22 . Although rich in detail of case reports, and although alluding to (relatively minor) improvements in anaesthetic administration methods, there was no mention of the underlying science sporadically being reported in contemporaneous reports. For his diligence and perseverance during this introductory period, Richard Ellis credited Robinson with the honour of being "England's true pioneer of anaesthesia" 23 .
Countless professional and lay publications concerned with the apparatus, techniques, clinical case reports and presentations to learned societies rapidly ensued in both the United States and Great Britain, with many containing replications of the same material. In the United States, many publications also were concerned with Morton's 'Letheon' and the originator of what would later be called 'surgical anaesthesia'. In Great Britain, however, a few publications, notably by John Snow and Andrew Buchanan, were also reporting significant scientific research and commentary.
The admixture with science was thus beginning, but only in Great Britain. 24 .
Snow: apothecary and 'medical man'
The first use of ether for general surgery in London had occurred on 21 December 1846 in the operating theatre of University College Hospital when Robert Liston operated on two patients. This was reported a week later in one perfunctory paragraph in The Medical Times that concluded "…We hope to have further particulars on this very interesting subject…" 25 An account "…given by Dr. [Sir John] Forbes [editor of the Medical Chirurgical Review]…" described Mr Liston's two cases -the first being that of the amputation at the thigh of a man [Frederick Churchill, aged 36, a butler 26 ] who had been "…previously narcotised by inhalation of ether vapour…" The second was that of the partial removal of the nail in onychia, on a man similarly narcotised, and "… with precisely the same result… In these cases, the ether vapour was administered by means of an ingenious apparatus extemporaneously contrived by Mr [Peter] Squire, of Oxford Street" [Peter Squire, Chemist in Ordinary, by appointment to Queen Victoria and the Royal Family, was the uncle of Liston's medical student, William Squire who administered the ether 27, 28 ]. The ether was administered by an improvised apparatus built around a sponge soaked in ether, from which the ether dripped downwards, and the vapour concentrated at the bottom of a collecting vase from which it was inspired through a flexible tube. It was explained in a footnote to the account that "No heat is required under any circumstances" 29 . Peter Squire also was interested in "…the various causes of non-success": it was largely, as he was reported in the meeting of the Pharmaceutical Society on 18 January 1847, due to the patients not taking sufficient ether 30 It was also reported that "…He (Dr Snow) was getting an instrument made which would enable the surgeon, merely by placing it in a bason [sic] of water, warmed or cooled to a given temperature, to administer an atmosphere of any strength he wished, and by this means to gain correct experience to guide him in the future". Snow acknowledged that the instrument was adapted from an inhaler designed [in 1842] "by a Mr [Julius] Jeffreys [FRS]".
On 23 January 1847, Snow presented to the Westminster Medical Society a new apparatus for inhaling the vapour of ether-with valves to prevent expired air returning to apparatus, built around a heat sink to regulate the temperature and thus the proportion of ether in air, and to preserve the temperature and thus saturation of the inhaled gas mixture. He had used it in one case "…at the temperature of seventy degrees, and it had produced the effects of ether, very powerfully, in half a minute" 32 .
During the first few months of 1847, frequent reports of the successful and unsuccessful uses of inhaled ether appeared in the main British medical journals, along with discussions of designs of masks and vaporisers, but the reports still were not considering the temperature of vaporisation as a variable. The importance of temperature in regulating the inspired ether concentration was repeatedly made by Snow, nowhere more forcefully than in his paper published in the London Medical Gazette of 19 and 26 March 1847. It started with this famously forceful admonition: It will be at once admitted that the medical practitioner ought to be acquainted with the strength of the various compounds which he applies as remedial agents, and that he ought, if possible, to be able to regulate their potency. The compound of ether vapour and of air is no exception to this rule... For, in the first place these effects vary materially according to the proportion of vapour given with the air, and in the next place, there is a counter process going on with inhalation, viz. exhalation. This increases with the amount of ether absorbed into the blood, and there arrives a point at which the exhalation may equal and just balance the inhalation, if the vapour be very much diluted; and this may occur before insensibility is produced. Snow then went on to describe the basis of vapour pressure measurement, and produced a revised table of the concentration of ether in air over the temperature range of 38 to 90°[F] to correct for the removal, by washing, of any alcohol residual from the production of the ether. He further explained how heat losses affected the inspired ether concentration, how the effects of ether appear in stages of increasing intensity 33 . The significance of how these assembled notions of Snow span the physical sciences and clinical speciality of anaesthesia has been addressed by Zuck 34 -and it is not an exaggeration to refer to them as enormous! Amid speculation that ether induced insensibility was due to asphyxia, at the meeting of the Westminster Medical Society of 13 February, Snow also considered-and then dismissed-that speculation 35 .
From early 1847, numerous reports with sketches of designs of ether vaporisers and mouth-pieces began to appear in the medical, scientific and lay literature. In particular, the Pharmaceutical Journal 36 included many, commencing with that by redesigned by Peter Squire for Robinson, and several designs that incorporated the ability to heat the ether, and thus avoid etherisation failures perceived to be due to the ether being too cold 37 . Each of these had been adapted from apparatus originally introduced for respiratory therapy, for example for treating hoarseness and asthma using substances including humidity or ammonia. Alfred Smee adapted such an earlier (1843) inhaler that also contained a separate hot water chamber for heating the ether. An ether vaporising apparatus created by James Startin was an adaption of his Pneumatic Inhaler (or Inspirator) originally devised in 1846 for respiratory therapy, mainly of factory workers exposed to noxious particles or gases as they worked, and could be heated to high temperatures to volatilise many substances 38 .
The most significant vaporiser, however, was the one adapted by John Snow from an inhaler, previously introduced by Julius Jeffreys as a humidifier, that included a heat sink to regulate temperature 39 . Its significance is twofold.
First, the editor of the Pharmaceutical Journal takes the trouble, in that March number, to somewhat cynically point out to readers that:
By a remarkable coincidence we find that an instrument identical in principle with that invented by Dr Snow, was invented some years ago by Mr Jeffery (sic) as an inhaler.
The circumstance reminds us of the case of the new planet, in which two rival discoverers are in the field.
In the April number 40 , Snow responded with much courtesy and firmness to point out that "…[it] is not a coincidence, but is the result of my previous acquaintance with the former [the Jeffreys apparatus]…and that I have never failed to mention the circumstance when saying or writing anything about the apparatus." Indeed, as noted above, Snow had acknowledged the original inventor in his presentation of the apparatus to the Westminster Medical Society. The editor of the Pharmaceutical Journal added a note to Snow's letter regretting "the observation we made last month which, from Dr Snow's statement, appears to have been erroneous".
Second, in presenting this vaporiser design, Snow stood apart from all others in demonstrating that he clearly understood the quantitative relationship between temperature and volatility as previously presented to the Westminster Medical Society.
In his response to the editor of the Pharmaceutical Journal, Snow took the opportunity to correct his previously published table relating the fractional composition of air containing ether as a function of temperature, writing that:
The table…is correct for ether, which is not free from alcohol, and boils at 104°. To make it correct for washed ether, which boils at 100° four degrees [Fahrenheit] must be deducted; …[for example, the 53.6% ether vapour listed for 74° is correct for 70°]…and for washed ether deprived of its water by potash, and boiling at 98°, six degrees must be deducted. 40 Snow reported his work on ether as it evolved and then, in September of 1847, he brought it together in a short book 41 . We are told that it "…was just beginning to sell, when the discovery of chloroform threw ether into the shade and the book with it" 42 .
From 1848 to 1851, whilst maintaining a now active and financially-sustaining anaesthetic practice, Snow wrote "On narcotism by the inhalation of vapours" 43 , a seminal series that contains many of the elements of what we would now call 'pharmacokinetics' and 'pharmacodynamics'.
In it, he developed a narrative around the importance of the vapour pressure of the anaesthetic agent, and its inspired and resultant blood concentrations. He described the physiological control over gas uptake, relating that gas moved across concentration gradients in the body (that we would now describe as alveolar to arterial to tissue to venous gas tensions), and he advocated a quantitative mass balance basis of the anaesthetic agent being used for surgical anaesthesia. He demonstrated that the physical variables of anaesthetic vapour inhalers and the rate of inhalation, as well as physiological variables, such as respiratory rate, were relevant to the induction of anaesthesia, and that attention to quantitation held the answer to avoiding 'etherisation failures'. He later attempted to calculate what we would now refer to as clearance, apparent distribution volume, and even measured the urinary excretion of a metabolite (chloride from chloroform).
Furthermore, Snow devised a semi-quantitative graded scale of five 'stages' of ether anaesthesia, which he observed during the induction and regression of anaesthesia. He performed a series of dose-response experiments of administration of numerous potential anaesthetic agents (including carbon disulphide and benzene!) in experiments on various species (mouse, rat, fish, guinea pig, cat, dog, bird, frog, human). He described the time-courses of anaesthesia on physiological functions, including oxygen consumption. He recognised the significance of relative safety, initially contrasting the convenience and agreeability of chloroform with the greater safety of the ether, and later comparisons with other possible agents. He calculated the relative solubilities of the agents in blood and air, and then ascertained that there was a relationship between their solubility in blood and their potency-the latter being again discovered by scientists including Overton and Meyer some five decades later.
The is little doubt that Snow's notions and observations of the mid-19th century laid foundations for what would become pharmacokinetics and pharmacodynamics a century later 44, 45 .
It is also interesting to note, without digressing into the education and training of the physicians, surgeons and apothecaries comprising the hierarchy of medical practitioners of the time, that the five-year apprenticeship preparation of surgeons and apothecaries, at least, involved significant teaching and examination in chemistry. By 1841, tensions between the 'chemists and druggists' regarding their examinations by the College of Physicians led to the establishment of the Pharmaceutical Society of Great Britain that would conduct its own examinations (although this new Society was not supported by the Society of Apothecaries 46 ). The Pharmaceutical Society meeting of 10 June 1846 included a report on the questions of candidates examined in chemistry, materia medica, and pharmacy. One of these questions was "Describe the mode of correcting the volumes of gases for pressure and temperature" 47 . This indicates that such knowledge was readily available and suggests that Snow could have been exposed to such thinking during his own training as an apothecary or through his 'druggist' colleagues, and thus could have put any such knowledge gained into his own research.
And finally we are told that Snow also "…paid considerable attention to the subject of local anaesthesia, and tried various methods for attaining to a knowledge of a perfect local anaesthetic." He did this in 1854 by cryo-anaesthesia with chloroform mixtures and solid carbon dioxide, but was never satisfied with the results "and soon relinquished the inquiry" 48 . Isolation of the cocaine alkaloid by Friedrich Gaedcke was described in 1855 49 , but Snow was unlikely to have known about this, and no such reference appeared in his subsequent writings.
Buchanan: surgeon and physiologist
Although this essay focuses on John Snow, it is helpful to introduce Andrew Buchanan (1798-1882) (Figure 3 ), formerly Professor of Materia Medica, Regius Professor of Theory of Physic (later Physiology), University of Glasgow (1839-76), who, contemporaneously with Snow, recognised that the administration of ether anaesthesia needed to be based on science.
During the first weeks of ether anaesthesia in Great Britain, Buchanan was invited to present a lecture to a mixed 'scientific' audience 50 . He started with his confessed scepticism about ether that was soon overcome "by actual observation and experiment". He then imparted scientific insights such as:
Ether… is admirably adapted to be administered by inhalation…the energy of its action, is proportionate to the degree in which the blood applied to the tissues of the heart and brain is impregnated with it. [And] …Now, on stopping the inhalation, the blood, circulating in the heart and brain, speedily passes off by the veins, and is succeeded by the comparatively pure blood coming from the lower regions of the body; and so the narcotic symptoms disappear… 51 He thus independently described prototypic pharmacokinetics and pharmacodynamics, but Buchanan was not recognised even by his own university for his contributions to the science of anaesthesia. Buchanan's erudite paper on ether was reprinted in the London Medical Gazette in three parts 51 . Interestingly, the paper immediately following the third part was titled 'Discovery of a new anaesthetic agent, more efficient than sulphuric ether' and its author was "J.Y. Simpson, MD Professor of Midwifery in the University of Edinburgh, Physician-Accoucheur to Her Majesty in Scotland, etc. etc." who soon overshadowed Scottish anaesthesia.
Snow specifically acknowledged Buchanan's contributions to these concepts, saying that "Dr Buchanan, by considering the quantity of ether expended in inhalation, and making allowance for what is expired, without being absorbed, considered the quantity in the blood of the adult in complete etherization to be not more than half a fluid ounce; and this is, I believe, a pretty correct estimate" 52 . Apart from designing some anaesthetic circuitry, Buchanan did little else in that discipline, instead becoming noted as one of the first to investigate the coagulation of the blood 53 .
Snow: anaesthetist and 'science man'
Snow's friend Benjamin Ward Richardson records that, on 10 June 1858, Snow completed the editing, except for the construction of the index, of his ultimate assembly of personal research embodied in "On chloroform and other anaesthetics: their action and administration". This was to be his last publication. Snow had an episode of a recurring giddiness a little earlier that morning, before returning to his editing, but what was to be a fatal stroke soon followed. His death occurred at 3pm on Wednesday, 16 June 1858. Richardson oversaw the production of the book in August of that year, and added a moving personal tribute in which he described Snow's grand search "for a narcotic vapour which, having the physical properties and practicability of chloroform, should, in its physiological effects, resemble ether in not producing, by any accident of administration, paralysis of the heart…" In the concluding paragraph, Richardson no longer refers to Snow as a "medical man" but, significantly, as a "science man" 54 . In a second, shortened memoir written some 30 years later, Richardson wrote that Snow's book "…will always remain as a memorable record in the history of medical literature" 55 . Indeed, Snow's works evolved to become the quantitative basis of anaesthesia. On 12 May 1847, in performing a pharmacological demonstration of ether anaesthesia to a medical audience at the United Service Institution, John Snow killed one of his experimental subjects-a bird 56 . He was explaining the comparative physiological pharmacology that:
The vapour of ether acts very in a very uniform manner on various classes of animals. The difference in the time they take to become affected and to recover, depends on the difference in the activity of the respiratory and circulating functions… Birds…are the most quickly brought under the influence of ether; they breathe more air in proportion to their size than other animals, and, consequently, inhale the vapour more quickly.
[Then]
This thrush…is dead. It ceased to breathe before I took it out of the jar. It is a result I did not intend, and it has arisen from my going on with the lecture, and looking at my notes, instead of directing my whole attention to the animal…but it does not follow that there is any danger in giving the vapour to a patient; for, of course, the medical man directs the whole of his attention to what he is doing. Indeed.
However, the science that Snow admixed with anaesthesia, again, was soon overwhelmed by clinical trials to find the ideal reliable, but nevertheless empirical, method of inhalation of ether and, next, of chloroform. Despite Snow's invention of a chloroform inhaler, again, designed from scientific understanding about vapour pressure and temperature 57 , open mask techniques of various kinds proliferated. Nonetheless, it is interesting to speculate that if Dr Snow had not performed that preclinical research of anaesthetic ether in those early days, killing a bird on the way, what has become the science of anaesthesia would surely have been delayed-or even worse!
Tribute
Remembering old friend and colleague John Gordon Roberts and the many hours we enjoyed discussing these matters, now over 40 years ago.
